How pharma companies can uncover the insights hidden in their contentFrom multichannel distribution to customer engagement to creative collaboration and beyond, the pharmaceutical industry is evolving the way Share XHow pharma companies can uncover the insights hidden in their contenthttps://pharmaphorum.com/whitepapers/how-pharma-companies-can-uncover-the-insights-hidden-in-their-content/
Investigator sponsored trials begin making waves in R&DIncreasing numbers of pharma companies are forgoing CROs to partner with academic centres on investigator sponsored trials (ISTs). Share XInvestigator sponsored trials begin making waves in R&Dhttps://pharmaphorum.com/r-d/views-analysis-r-d/investigator-sponsored-trials-begin-to-make-waves-in-rd/
Learning from online patient peer support groupsOnline patient communities have become a staple part of the healthcare landscape in recent years, presenting the sector Share XLearning from online patient peer support groupshttps://deep-dive.pharmaphorum.com/magazine/patient-engagement/learning-from-online-patient-peer-support-groups/
Simplicity, practicality and accessibility – primary care physicians’ clinical guideline needsNew clinical practice guidelines emerge at such a speed that it is all but impossible for primary care Share XSimplicity, practicality and accessibility – primary care physicians’ clinical guideline needshttps://pharmaphorum.com/views-and-analysis/simplicity-practicality-and-accessibility-primary-care-physicians-clinical-guideline-needs/
Livongo looks to set itself apart from digital health rivalsPaul Tunnah sat down with Livongo’s CEO Zane Burke to discuss how he has applied lessons from bigger Share XLivongo looks to set itself apart from digital health rivalshttps://pharmaphorum.com/views-analysis-digital/livongo-looks-to-set-itself-apart-from-digital-health-rivals/
Making real world evidence fit for purposeAlthough real world evidence (RWE) is a hot topic in pharma right now, many still question whether it Share XMaking real world evidence fit for purposehttps://pharmaphorum.com/views-analysis-market-access/making-real-world-evidence-fit-for-purpose/
The three biggest challenges in lung cancer, and how researchers are tackling themDespite new paradigm-shifting treatments, lung cancer remains a deadly disease – and improving outcomes requires more than just Share XThe three biggest challenges in lung cancer, and how researchers are tackling themhttps://pharmaphorum.com/views-and-analysis/the-three-biggest-challenges-in-lung-cancer-and-how-researchers-are-tackling-them/
Welcome to ‘Generation R’ for the next decade of patient engagementRelationship recrudescence; inertia, cynicism and complacency must not prevail, says Nexgen Healthcare Communications’ Emma Sutcliffe “Are patients too Share XWelcome to ‘Generation R’ for the next decade of patient engagementhttps://deep-dive.pharmaphorum.com/magazine/patient-engagement/welcome-to-generation-r-for-the-next-decade-of-patient-engagement-nexgen/
Digital health literacy: the bright tail of the cometWe have just entered 2020, a year that marks the point of arrival of many global and national Share XDigital health literacy: the bright tail of the comethttps://pharmaphorum.com/views-analysis-digital/digital-health-literacy-the-bright-tail-of-the-comet/
